Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological| biomedical| agricultural and environmental sciences as well as covers the commercial| political| ethical| legal| and societal aspects of this research. The first function is fulfilled by the peer-reviewed research section| the second by the expository efforts in the front of the journal. We provide researchers with news about business; we provide the business community with news about research developments. The core areas in which we are actively seeking research papers include: molecular engineering of nucleic acids and proteins; molecular therapy (therapeutics genes| antisense| siRNAs| aptamers| DNAzymes| ribozymes| peptides| proteins); large-scale biology (genomics| functional genomics| proteomics| structural genomics| metabolomics| etc.); computational biology (algorithms and modeling)| regenerative medicine (stem cells| tissue engineering| biomaterials); imaging technology; analytical biotechnology (sensors/detectors for analytes/macromolecules)| applied immunology (antibody engineering| xenotransplantation| T-cell therapies); food and agricultural biotechnology; and environmental biotechnology. A comprehensive list of areas of interest is shown below.
数据整理自公开网络的投稿反馈，仅供参考。
